logo
Select company
Select metric
4.97Current Ratio
VS
Market
83
Sector
64
Industry
50
History
40
$ 36.02Close
$ 29.84 - $ 61.8 52-Week Range
Ticker Information

Ticker

VCEL

Company Name

VERICEL CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VERICEL CORP - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VCEL - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 204.58M4.97$ 41.13M
3/31/2025$ 197.64M5.01$ 39.45M
12/31/2024$ 212.78M4.23$ 50.29M
9/30/2024$ 190.52M4.61$ 41.35M
6/30/2024$ 197.39M4.5$ 43.86M
3/31/2024$ 189.72M5.2$ 36.47M
12/31/2023$ 205.63M4.49$ 45.75M
9/30/2023$ 186.21M5.18$ 35.95M
6/30/2023$ 182.87M5.14$ 35.61M
3/31/2023$ 177.54M6.17$ 28.75M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VERICEL CORP's latest trailing twelve months (TTM) Current Ratio stands at 5.88.
  • Over the past 5 years, VERICEL CORP's average Current Ratio has been 5.51.
  • The median Current Ratio for VERICEL CORP during this period was 5.34
  • VERICEL CORP reached its highest Current Ratio over the past 5 years at 7.7.
  • The lowest Current Ratio recorded by VERICEL CORP in the same timeframe 4.23

VERICEL CORP's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
ARQT : ARCUTIS BIOTHERAPEUTICS INC 3.2TARS : TARSUS PHARMACEUTICALS INC 5.26ADPT : ADAPTIVE BIOTECHNOLOGIES CORP 2.84AUPH : AURINIA PHARMACEUTICALS INC 5.23XERS : XERIS BIOPHARMA HOLDINGS INC 1.95TVTX : TRAVERE THERAPEUTICS INC 2RCUS : ARCUS BIOSCIENCES INC 4.5IOVA : IOVANCE BIOTHERAPEUTICS INC 3.27IMCR : IMMUNOCORE HOLDINGS PLC 5.89MNKD : MANNKIND CORP 2.5

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for VERICEL CORP is calculated as follows: AssetsC [ $ 125.38M ] / LiabilitesC [ $ 21.31M ]
(=) Current Ratio [ 5.88 ]

VCEL - Current Ratio, Last 5 years

4.23

Minimum

Dec 31, 2024

7.7

Maximum

Sep 30, 2021

5.51

Average

5.34

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44